Lanean...
Histopathology-validated machine learning radiographic biomarker for non-invasive discrimination between true progression and pseudo-progression in glioblastoma
PURPOSE: Imaging of glioblastoma patients after maximal safe resection and chemoradiation commonly demonstrates new enhancement concerning for true tumor progression (TP). However, in 30–50% of patients, this enhancement primarily represents treatment effect, or pseudo-progression (PsP). We hypothes...
Gorde:
| Argitaratua izan da: | Cancer |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7893811/ https://ncbi.nlm.nih.gov/pubmed/32129893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32790 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|